We are committed to launching products that make a difference in people’s lives. We work across a product’s lifecycle, supporting biotech, pharmaceutical, and medical technology companies across the globe.
Our team provide unequalled accuracy and quality whilst delivering all aspects of systematic reviews, meta-analyses and patient-level data analyses.
We develop a range of robust health economic models that meet the commercial needs of our clients from simple Markov models to complex discrete event simulations.
Health Technology Assessment
We have extensive experience delivering successful HTA submissions in the UK and across the globe.
We effectively communicate the value of your products in a logical and insightful manner; from internal value dossiers to external scientific publications.
Pricing & Reimbursement
We partner with our clients to develop strategies for global pricing and reimbursement, harnessing our extensive KOL and payer network.
“FIECON exceeds my expectations by genuinely trying to achieve the best outcomes for our company. Their flexibility to adapt to unexpected changes and apply technical rigour, while respecting the commercial focus of the company is unparalleled. We see FIECON as part of our extended team.”Senior Market Access Manager, Mid-sized Pharma
“It was brilliantly smart and very well explained. It seems obvious now but that is what genius is, making complex things appear simple.”Associate Director, Mid-sized Pharma
“FIECON are my go to trusted partner. The team deliver high-quality work to timeline, every time. But more than this, FIECON has worked as part of our team, working towards achieving the best possible outcome by providing high level strategic input and challenge during our discussions.”Market Access Director, Small Biotech
“FIECON’s highly skilled expert team helped us to successfully tackle a number of tough pricing and access challenges. Apart from their flawless technical expertise, we have a reliable thought partner to pressure test new ideas and strategies that have a broader relevance than purely health economic aspects.”Disease Area Director, Big Pharma
“The pricing and market access research was a high quality work project, which included detailed information to define the overall and country strategy while the gap analysis was instrumental in the next steps preparation. ”Executive Director, Biotech
“FIECON’s strategic approach to problem solving is a breath of fresh air. We highly value their HTA knowledge and expertise, and they consistently deliver the best solution for us.”Value Demonstration & Access Lead, Big Pharma
“It is a pleasure to work with FIECON. The team are passionate about what they do and it really shows in their high-quality, creative solutions. Working with FIECON gives your projects the highest chance of success.”Senior Vice President, Small Biotech
“FIECON’s team is highly experienced, commercially focused, responsive and flexible. A particular strength I highlight is that FIECON’s team becomes a true partner with all company functions that they interact with. ”Executive Director, Biotech
COMMERCIALISATION IN EUROPE
Our white paper 'Is European market access becoming an incubator for rare disease development?' explores the hypothesis that successful commercialisation in Europe is the biggest commercial opportunity for orphan drug manufacturers right now. Find out more about how you can navigate European changes with the support of a trusted vendor to achieve maximum global profit by downloading the white paper.
PATIENT PERSPECTIVES PODCASTS
Patient advocacy is now the key to a successful product launch. Establishing relationships between patient advocacy groups and the pharmaceutical industry will ensure objective measures of efficacy are realised, and improved patient outcomes are achieved.
FIECON has launched a series of podcasts, talking to patients and patient advocacy leaders about the burden, unmet needs, patient journey and possible future treatment options to better understand the patient perspective.
Our hope is that a more comprehensive understanding of that patient perspective will help to optimise drug development, expenditures, and care into the future.
OVER 50 GLOBAL HTA SUBMISSIONS
We have delivered over 50 global HTA submissions in the last three years, with a success rate exceeding 90% across all indications, 100% in orphan conditions! We have a wealth of experience and knowledge that we utilize to navigate the requirements and nuances of HTA processes to ensure market access and a commercially acceptable price.
PLATINUM AWARD WINNER 2021/22
We were delighted to be recognised for our outstanding contribution to workplace philanthropy and presented with the Platinum Award for our Payroll Giving efforts in 2021/22, by the Charities Trust.
Payroll Giving is one of the most effective ways to give. It offers a simple way for our team members to donate to the good causes they are passionate about, tax free, direct from their pay and provides a regular income for the charities they support.
We support and encourage our people to give back to causes close to their hearts by matching Payroll Giving donations too.
MODELS IN MINUTES
FIECON Model Builder is an online platform which automates the design and building-process of Excel-based cost-effectiveness models. High quality Excel models can be built in a matter of minutes rather than weeks. Models are set up with complete functionality, flexibility, and transparency. But most importantly our automated process removes the risk of human error and guarantees accuracy. Give yourself the best chance of success; save time and money with the right cost-effectiveness model from FIECON Model Builder.
Get in touch with our Head of Business Development, Karl Freemyer - email@example.com, to book a demo or find out more.
HOLISTIC MARKET ACCESS PLATFORM
FIECON Value Platform can help you manage and optimise your product’s pricing and market access processes. Your online portal helps Global teams quickly understand progress, priorities, and support needs in local markets, saving you time, increasing team efficiency, and ensuring unity and alignment. Save time, increase efficiency and ensure unity and alignment to give your products the best chance of achieving successful pricing and market access.
Get in touch with our Pricing and Market Access Director, Martin Schuchardt, to book a demo or find out more.